4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride hydrate, 95%, 5g

tert-butyl [(1S)-1-(5-mercapto-1,3,4-oxadiazol-2-yl)ethyl]carbamate, 97.0%, 1g

Heptanoic acid, 97.0%, 25g

ETHYL 3-(2-CHLOROPHENYL)ACRYLATE, 95.0%, 1g

1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene, 95.0%, 100g

(1H-PYRAZOL-3-YL)-ACETIC ACID ETHYL ESTER, 95.0%, 25g

1-Bromo-4-fluoro-2-methoxy-5-nitrobenzene, 98.0%, 5g

7-(Bromomethyl)pentadecane>95.0%(GC)5mL

5-Bromo-2-methyl-2H-tetrazole, 97%, 100mg

2-(4-Chloro-2,6-dimethylphenoxy)acetic acid, 98%, 5g

2-(2,3-Difluorobenzoyl)oxazole, 97.0%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 1.00 µm, 1 Piece(s)

2-Methyl-3-trifluoromethylaniline>99.0%(GC)5g